Company Filing History:
1 out of 3 
1 out of 832,912 Years Active: 2008-2015
Title: The Innovative Contributions of Vito M Fazio
Introduction
Vito M Fazio is an accomplished inventor based in Rome, Italy, known for his significant contributions to the field of immunology. With a total of two patents to his name, his work primarily focuses on developing immunogenic peptides and DNA vaccines that target various cancer types, showcasing his commitment to advancing medical science.
Latest Patents
Vito M Fazio's latest patents include the following innovations:
1. **Anti-Tumoral Immunogenic Peptides and Vaccine Thereof**: This invention relates to novel, Frizzled-like, immunogenic peptides that are useful for stimulating an immune response against various cancer types, particularly colon rectal carcinoma.
2. **DNA Vaccines Expressing Hypervariable VH-CDR3 Idiotypic Determinants**: This method induces the immune response of an individual against B-lymphoproliferative disorders. It utilizes DNA vaccination with a peptide encompassing the CDR3 hypervariable region of the immunoglobulin heavy chain (VH-CDR3), either alone or in combination with additional immunomodulating sequences.
Career Highlights
Vito has worked with notable companies including Keryos SpA, where he contributed his expertise in immunology and vaccine development. His career reflects a strong alignment with innovative research focused on enhancing immune responses to combat cancer and other disorders.
Collaborations
Throughout his career, Vito M Fazio has collaborated with respected colleagues such as Enrico Garaci and Guido Rasi. These partnerships highlight his integration within the scientific community, fostering innovation and furthering research in immunology.
Conclusion
Vito M Fazio's work exemplifies the vital connection between innovation and healthcare advancements. His patents not only demonstrate technical ingenuity but also serve as a testament to his commitment to developing solutions that address pressing medical challenges. As he continues to innovate, his contributions will likely play a significant role in shaping future treatments for cancer and other diseases.